NCT02430753View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

February 1, 2021

Conditions
Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Interventions
PROCEDURE

Irreversible electroporation (IRE)

Irreversible Electroportion For Lung Neoplasms accompanied by Respiratory Function Insufficiency guide with ultrasound or/and CT.

DEVICE

NanoKnife

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02430753 - Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency | Biotech Hunter | Biotech Hunter